Radiosensitization of non-small cell lung carcinoma by EGFR inhibition

Radiosensitization of non-small cell lung carcinoma by EGFR inhibition

Molecular targeted cancer therapy is a promising treatment strategy. Considering the central role of the epidermal growth factor receptor in cell proliferation and survival, there are indications that targeted agents like tyrosine kinase inhibitors, i. e., erlotinib, may enhance the antitum...

Full description

Bibliographic Details
Main Authors: Keta Otilija D., Bulat Tanja M., Korićanac Lela B., Žakula Jelena J., Cuttone Giacomo, Privitera Giuseppe, Petrović Ivan M., Ristić-Fira Aleksandra M.
Format: Article
Language:English
Published: VINCA Institute of Nuclear Sciences 2014-01-01
Series:Nuclear Technology and Radiation Protection
Subjects:
human lung adenocarcinoma cell
γ-ray
DNA damage
erlotinib
radiosensitization
Online Access:http://www.doiserbia.nb.rs/img/doi/1451-3994/2014/1451-39941403233K.pdf

Similar Items

Similar Items